Glassman Wealth Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11
Closed -$281 2000
2023
Q2
$281 Buy
+11
New +$290 ﹤0.01% 1751
2020
Q1
Sell
-8
Closed 1130
2019
Q4
$0 Buy
8
+1
+14% +$36 ﹤0.01% 1173
2019
Q3
$0 Sell
7
-3
-30% -$114 ﹤0.01% 1045
2019
Q2
$0 Buy
10
+5
+100% +$214 ﹤0.01% 1070
2019
Q1
$0 Buy
+5
New +$224 ﹤0.01% 1025
2016
Q1
Sell
-26
Closed -$1K 425
2015
Q4
$1K Buy
+26
New +$808 ﹤0.01% 404

Other funds holding AVNS

Glassman Wealth Services's AVNS Position: Q3 2023 in Review

Glassman Wealth Services sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 11 shares — an estimated $281 sold.

Glassman Wealth Services first reported a position in AVNS in Q4 2015 and held it in 6 quarters. The position peaked at $1K in Q4 2015. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Glassman Wealth Services reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 11 Avanos Medical shares in Q3 2023, an estimated $281.
  • Glassman Wealth Services first reported a position in Avanos Medical in Q4 2015 and held it in 6 quarters.
  • Glassman Wealth Services's Avanos Medical position peaked at $1K in Q4 2015.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.